Helga H Hektoen

8PUBLICATIONS
10CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 08, 2026
Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities.

|Apr 29, 2025
Let's talk about sex: Survival among females and males in a real-world cohort treated with pembrolizumab for non-small cell lung cancer.

Kaitlyn M Tsuruda, Helga H Hektoen, Christina Aamelfot

|Feb 17, 2025
Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancer.

Kaitlyn M Tsuruda, Helga H Hektoen, Denise Reis Costa

|Feb 10, 2023
Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway.

T E Robsahm, K M Tsuruda, H H Hektoen

|Nov 22, 2021
Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter].

Bettina K Andreassen, Helga H Hektoen, Karol Axcrona

|Sep 22, 2021
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort.

Helga H Hektoen, Randi E Gislefoss, Jo S Stenehjem

Pageof 2

Frequent Collaborators

5 joint publications

Trude E Robsahm

4 joint publications

Jo S Stenehjem

3 joint publications

Kaitlyn M Tsuruda

2 joint publications

Bettina Kulle Andreassen